Integra LifeSciences Quarterly Balance Sheet
NASDAQ: IARTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Integra LifeSciences financial position
As of Jun 30, 2026, Integra LifeSciences reported total assets of $3.56 billion, down 2.8% from a year earlier against total liabilities of $2.52 billion. Shareholders' equity stood at $1.04 billion, or 29.3% of assets. The company held $214.4 million in cash and equivalents against $707.2 million of debt, a net debt position of $492.8 million.
The current ratio (current assets divided by current liabilities) was 3.60, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.68.
Summary generated from market data by MetaCap's automated system. Methodology
Integra LifeSciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 214.41M | 236.81M | 235.05M | 232.19M | 217.91M | 239.10M | 246.38M | 215.16M | 215.24M | 591.91M | 276.40M | 273.73M |
| Short-Term Investments | 59.67M | 28.69M | 28.69M | 35.69M | 35.69M | 34.19M | 27.19M | 62.44M | 81.69M | 71.19M | 32.69M | — |
| Receivables | 267.19M | 264.41M | 278.85M | 262.16M | 284.51M | 252.45M | 272.37M | 248.30M | 271.15M | 241.09M | 259.33M | 256.27M |
| Inventory | 492.00M | 495.04M | 492.74M | 489.11M | 465.13M | 445.42M | 429.09M | 436.93M | 421.77M | 403.42M | 389.61M | 366.25M |
| Total Current Assets | 1.19B | 1.17B | 1.16B | 1.14B | 1.14B | 1.11B | 1.08B | 1.10B | 1.11B | 1.42B | 1.06B | 1.03B |
| Property, Plant & Equipment | 446.20M | 446.88M | 444.33M | 437.37M | 434.82M | 422.91M | 405.72M | 390.91M | 373.57M | 345.36M | 340.20M | 318.72M |
| Goodwill | 611.14M | 613.25M | 615.16M | 615.20M | 616.43M | 1.11B | 1.10B | 1.12B | 1.10B | 1.04B | 1.06B | 1.04B |
| Intangible Assets | 1.08B | 1.11B | 1.13B | 1.16B | 1.19B | 1.19B | 1.21B | 1.21B | 1.22B | 1.02B | 1.07B | 1.07B |
| Total Assets | 3.56B | 3.58B | 3.60B | 3.65B | 3.67B | 4.05B | 4.04B | 4.07B | 4.07B | 4.08B | 3.78B | 3.74B |
| Accounts Payable | 82.64M | 87.95M | 95.73M | 92.31M | 92.83M | 91.30M | 82.50M | 77.67M | 107.49M | 94.40M | 92.33M | 93.55M |
| Total Current Liabilities | 330.88M | 346.85M | 455.98M | 364.05M | 929.81M | 918.45M | 922.13M | 912.56M | 328.32M | 302.39M | 306.98M | 355.71M |
| Long-Term Debt | 707.19M | 716.88M | 726.56M | 736.25M | 745.94M | 755.63M | 760.47M | 765.31M | 770.16M | 775.00M | 775.00M | 775.00M |
| Total Liabilities | 2.52B | 2.54B | 2.56B | 2.61B | 2.63B | 2.53B | 2.49B | 2.54B | 2.54B | 2.48B | 2.19B | 2.16B |
| Shareholders' Equity | 1.04B | 1.04B | 1.04B | 1.04B | 1.04B | 1.52B | 1.55B | 1.52B | 1.53B | 1.60B | 1.59B | 1.58B |
| Retained Earnings | 423.31M | 418.82M | 423.44M | 425.14M | 430.55M | 914.62M | 939.91M | 920.48M | 931.18M | 943.58M | 946.86M | 927.02M |
| Total Debt | 707.19M | 716.88M | 726.56M | 736.25M | 745.94M | 755.63M | 760.47M | 765.31M | 770.16M | 775.00M | 775.00M | 775.00M |
| Net Cash (Debt) | -433.10M | -451.37M | -462.82M | -468.37M | -492.33M | -482.33M | -486.90M | -487.71M | -473.23M | -111.90M | -465.90M | -501.27M |
This table shows 12 quarterly periods of Integra LifeSciences's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IART's reporting calendar. What is a balance sheet?